InvestorsHub Logo

hoosierdaddyof3

07/01/21 6:49 PM

#6594 RE: Paulness #6593

Painless, you certainly enjoy expounding the news. The obvious question would be: Does it pay well?

Doctor_Hari_Seldon

07/01/21 7:29 PM

#6595 RE: Paulness #6593

It has always amazed me how much under the radar this stock really is. The capitalization value is so low, it just is not followed enough for good or bad news to effect it much. This is quite good news. People in the Parkinson's arena also recognize that any study of efficacy that must be done over a long period can be weighted downward by the tendency for the disease to have naturally progressed at various rates among the trial patients. i.e. - halting deterioration would be a positive sign, near 50% improvement is more than that.

The news is not really out much yet though. Although in the Parkinson's Parkinson's News Today, they put this out today:

https://parkinsonsnewstoday.com/2021/07/01/stem-cell-therapy-shows-safety-potential-efficacy-in-early-clinical-trial/